Journal Highlight : Gene Therapy
The journal welcomes scholarly contributions related to the development and application of genetic technologies for the prevention, treatment, and management of diseases. This section focuses on research that advances gene-based therapeutic strategies, molecular medicine, and translational biomedical approaches aimed at correcting or modifying genetic and cellular dysfunction.
The journal encourages submissions in areas including Gene Editing Technologies, CRISPR and Genome Engineering, Viral and Non-Viral Gene Delivery Systems, Cell and Gene Therapy, RNA-Based Therapeutics, Genetic Medicine, Stem Cell-Based Gene Therapies, Molecular Therapeutics, and Precision and Personalized Medicine. Research related to Cancer Gene Therapy, Inherited Genetic Disorders, Neurogenetic Diseases, Cardiovascular and Metabolic Gene Therapies, Immunogene Therapy, and Regenerative Genetic Approaches is also welcomed.
Submissions focusing on Therapeutic Gene Target Identification, Gene Expression Regulation, Biomarker-Guided Gene Therapy, Translational and Clinical Gene Therapy Research, Safety and Efficacy of Gene-Based Treatments, AI and Bioinformatics in Gene Therapy Development, Advanced Vector Engineering, and Ethical and Regulatory Aspects of Genetic Therapies are encouraged. The journal also welcomes studies investigating therapeutic mechanisms, delivery optimization, long-term treatment outcomes, immune responses, and innovative gene-based interventions across diverse disease conditions.
Accepted manuscript types include Original Research Articles, Systematic Reviews, Meta-Analyses, Experimental and Clinical Studies, Preclinical Research Articles, Methodology and Technical Reports, and Translational Biomedical Studies that contribute to advancements in gene therapy and molecular medicine.
Through this focus area, the journal aims to support research that advances genetic therapeutic technologies, strengthens translational and precision medicine, improves treatment strategies for genetic and acquired diseases, and contributes to innovation in biomedical and molecular sciences worldwide.
